Format

Send to

Choose Destination
Rev Esp Enferm Dig. 2017 Oct;109(10):684-689. doi: 10.17235/reed.2017.4951/2017.

Pancreatic enzyme replacement therapy in cystic fibrosis: dose, variability and coefficient of fat absorption.

Author information

1
Gastroenterología y Hematología Pediátrica, Instituto de Investigación Sanitaria La Fe, España.
2
Enfermedad Celiaca e Inmunopatología digestiva, Instituto de Investigación Sanitaria La Fe, Valencia, España.
3
Gastroenterología y Hepatología Pediátrica,, Hospital Universitario y Politécnico La Fe,.
4
Bioestadística, Instituto de Investigación Sanitaria La Fe, Valencia.

Abstract

OBJECTIVES:

Pancreatic enzyme replacement therapy (PERT) remains a backbone in the nutritional treatment of cystic fibrosis. Currently, there is a lack of an evidence-based tool that allows dose adjustment. To date, no studies have found an association between PERT dose and fat absorption. Therefore, the aim of the study was to assess the influence of both the PERT dose and the variability in this dose on the coefficient of fat absorption (CFA).

METHODS:

This is a retrospective longitudinal study of 16 pediatric patients (192 food records) with three consecutive visits to the hospital over a twelve-month period. Dietary fat intake and PERT were assessed via a four-day food record and fat content in stools was determined by means of a three-day stool sample collection. A beta regression model was built to explain the association between the CFA and the interaction between the PERT dose (lipase units [LU]/g dietary fat) and the variability in the PERT dose (standard deviation [SD]).

RESULTS:

The coefficient of fat absorption increased with the PERT dose when the variability in the dose was low. In contrast, even at the highest PERT dose values, the CFA decreased when the variability was high. The confidence interval suggested an association, although the analysis was not statistically significant.

CONCLUSION:

The variability in the PERT dose adjustment should be taken into consideration when performing studies on PERT efficiency. A clinical goal should be the maintenance of a constant PERT dose rather than trying to obtain an optimal value.

PMID:
28747058
DOI:
10.17235/reed.2017.4951/2017
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Aran ediciones, S.L.
Loading ...
Support Center